BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25488097)

  • 1. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis.
    Anderson K; Stowasser D; Freeman C; Scott I
    BMJ Open; 2014 Dec; 4(12):e006544. PubMed ID: 25488097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review.
    Xu Z; Liang X; Zhu Y; Lu Y; Ye Y; Fang L; Qian Y
    Fam Med Community Health; 2021 Nov; 9(4):. PubMed ID: 34794961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medicine prescribing by nurse practitioners in New Zealand.
    Poot B; Nelson K; Zonneveld R; Weatherall M
    J Am Assoc Nurse Pract; 2020 Mar; 32(3):220-228. PubMed ID: 31369453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient barriers to and enablers of deprescribing: a systematic review.
    Reeve E; To J; Hendrix I; Shakib S; Roberts MS; Wiese MD
    Drugs Aging; 2013 Oct; 30(10):793-807. PubMed ID: 23912674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoke-free homes: what are the barriers, motivators and enablers? A qualitative systematic review and thematic synthesis.
    Passey ME; Longman JM; Robinson J; Wiggers J; Jones LL
    BMJ Open; 2016 Mar; 6(3):e010260. PubMed ID: 26988351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.
    Tangiisuran B; Rajendran V; Sha'aban A; Daud NAA; Nawi SNM
    Int J Clin Pharm; 2022 Feb; 44(1):201-213. PubMed ID: 34642869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The knowledge, attitudes and beliefs of patients and their healthcare professionals around oral dosage form modification: A systematic review of the qualitative literature.
    Mc Gillicuddy A; Kelly M; Crean AM; Sahm LJ
    Res Social Adm Pharm; 2017; 13(4):717-726. PubMed ID: 27729203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially inappropriate medications in community-dwelling older adults undertaken as a comprehensive geriatric risk assessment.
    Bala SS; Narayan SW; Nishtala PS
    Eur J Clin Pharmacol; 2018 May; 74(5):645-653. PubMed ID: 29330585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
    Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
    Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis.
    Kinnear FJ; Wainwright E; Perry R; Lithander FE; Bayly G; Huntley A; Cox J; Shield JP; Searle A
    BMJ Open; 2019 Jul; 9(7):e030290. PubMed ID: 31371299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.
    Wallis KA; Andrews A; Henderson M
    Ann Fam Med; 2017 Jul; 15(4):341-346. PubMed ID: 28694270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescriber perspectives on low-value prescribing: A qualitative study.
    Walter EL; Dawdani A; Decker A; Hamm ME; Pickering AN; Hanlon JT; Thorpe CT; Roberts MS; Fine MJ; Gellad WF; Radomski TR
    J Am Geriatr Soc; 2021 Jun; 69(6):1500-1507. PubMed ID: 33710629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of potentially inappropriate medication use in residential aged care facilities.
    Harrison SL; Kouladjian O'Donnell L; Milte R; Dyer SM; Gnanamanickam ES; Bradley C; Liu E; Hilmer SN; Crotty M
    BMC Geriatr; 2018 Jan; 18(1):9. PubMed ID: 29325531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches.
    Lindsay J; Dooley M; Martin J; Fay M; Kearney A; Barras M
    Support Care Cancer; 2014 Apr; 22(4):1113-9. PubMed ID: 24362845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-synthesis of potentially inappropriate prescribing in older patients.
    Cullinan S; O'Mahony D; Fleming A; Byrne S
    Drugs Aging; 2014 Aug; 31(8):631-8. PubMed ID: 24923385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study.
    Millar A; Hughes C; Ryan C
    Int J Clin Pharm; 2017 Jun; 39(3):527-535. PubMed ID: 28315116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.